Comprehensive medication guide to Kerendia including estimated pricing, availability information, side effects, and how to find it in stock at your local pharmacy.
Estimated Insurance Pricing
$0–$50 copay with commercial insurance; Tier 3–4 brand, prior authorization typically required.
Estimated Cash Pricing
$670–$950 for a 30-tablet supply; Bayer's Savings Card may reduce copay to $0 for commercially insured patients.
Medfinder Findability Score
65/100
Summarize with AI
On this page
Kerendia (Finerenone) is a non-steroidal mineralocorticoid receptor antagonist (MRA) manufactured by Bayer Healthcare. It is FDA-approved to reduce the risk of kidney function decline, kidney failure, cardiovascular death, non-fatal heart attacks, and hospitalization for heart failure in adults with chronic kidney disease (CKD) associated with type 2 diabetes. It is also approved to reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure and a left ventricular ejection fraction of 40% or greater (HFpEF/HFmrEF).
Kerendia works by blocking the activity of mineralocorticoid receptors in the body. When these receptors are overactivated — which commonly occurs in patients with CKD and type 2 diabetes — they drive inflammation and fibrosis (scarring) in the kidneys and heart. By selectively blocking these receptors, Finerenone reduces this harmful inflammation and scarring, helping to slow kidney disease progression and lower cardiovascular risk. Unlike older MRAs such as Spironolactone, Kerendia is non-steroidal, which means it has a more targeted mechanism and fewer hormonal side effects.
We have a 99% success rate finding medications, even during nationwide shortages.
Need this medication?
10 mg film-coated tablet — tablet
20 mg film-coated tablet — tablet
Kerendia (Finerenone) is a brand-name specialty medication with no generic equivalent. It is not currently listed on the FDA Drug Shortage database and has not experienced significant supply disruptions since its approval in July 2021. However, because it is a single-source specialty product, not all pharmacies routinely stock it. Patients may need to check specialty or larger chain pharmacies. Using Medfinder can help locate pharmacies that have Kerendia available near you.
Kerendia is most commonly prescribed by nephrologists, endocrinologists, and cardiologists. Internal medicine physicians and primary care or family medicine doctors may also prescribe it, particularly when managing patients with both type 2 diabetes and chronic kidney disease. Telehealth consultations are available for Kerendia prescriptions.
No. Kerendia is not a controlled substance and does not have a DEA schedule. It does not carry a risk of abuse or dependence, and no special prescribing restrictions apply beyond standard prescription requirements.
Serious side effects may include severe hyperkalemia causing heart palpitations, irregular heartbeat, muscle weakness, or numbness, as well as severe hypotension or hyponatremia. Contact your doctor immediately if you experience any of these symptoms.
Know what you need? Skip the search.
Spironolactone
A steroidal mineralocorticoid receptor antagonist available as an affordable generic. It is widely used but has more side effects such as gynecomastia and sexual dysfunction due to cross-reactivity with androgen and progesterone receptors.
Eplerenone
Another steroidal MRA with better selectivity than Spironolactone but less potent. Available as a generic, primarily indicated for heart failure and hypertension.
Dapagliflozin (Farxiga)
An SGLT2 inhibitor approved for CKD with or without diabetes. Different mechanism but also provides kidney and heart protection.
Empagliflozin (Jardiance)
An SGLT2 inhibitor with CKD and heart failure indications, often used alongside or as an alternative kidney-protective therapy.
Prefer Kerendia? We can find it.
Strong CYP3A4 inhibitors
moderate(Itraconazole, Ketoconazole, Ritonavir, Clarithromycin, Voriconazole) — contraindicated , do not use together
Strong CYP3A4 inducers
moderate(Rifampin, Carbamazepine, Phenytoin, St. John's Wort) — avoid, as they significantly reduce Kerendia's effectiveness
Moderate CYP3A4 inhibitors
moderate(Erythromycin, Diltiazem, Verapamil, Fluconazole) — dose adjustment may be needed
Potassium supplements and potassium-sparing diuretics
moderateincreased risk of dangerous hyperkalemia
NSAIDs
moderatemay increase potassium levels and reduce kidney function
Grapefruit and grapefruit juice
moderateavoid, as they increase Finerenone levels in the blood
Kerendia represents an important advance in treating chronic kidney disease associated with type 2 diabetes and heart failure with preserved ejection fraction. As a non-steroidal MRA, it offers a more targeted approach with fewer hormonal side effects compared to older alternatives like Spironolactone. While the cash price of $670–$950 per month is significant, Bayer's Savings Card can reduce costs to $0 for commercially insured patients, and patient assistance programs are available for uninsured or underinsured individuals. The main consideration is regular potassium monitoring due to the risk of hyperkalemia. If you're having trouble finding Kerendia at your local pharmacy, try using Medfinder to locate it in stock near you.
Medfinder Editorial Standards
Our medication guides are researched and written to help patients make informed decisions. All content is reviewed for accuracy and updated regularly. Learn more about our standards
ChatGPT
Claude
Perplexity
Grok
Gemini